Form D · Biotechnology
VST Operating Corp.
Mequon, WI · CIK 0002135476
Offering snapshot reported May 15, 2026 · SEC filing
- Reported sold
- $1.68M Offering amount: $2.19M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2026 | Initial | $1,684,732 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $62.2K
- Form D file number
- 021-584265
Source: Form D, filed May 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Bachinski | Director, Executive |
| Stephen Gledhill | Executive |
| Barry G Hix | Director, Executive |
| William Jackson | Director, Executive |
| Tommy Thompson | Director, Executive |
| W. Bradley G Worthington | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12250 Corporate Parkway
Mequon, WI, 53902
Mequon, WI, 53902